Skip to main content

Table 1 Target clinical behaviours for T3 trial

From: Development of a theory-informed implementation intervention to improve the triage, treatment and transfer of stroke patients in emergency departments using the Theoretical Domains Framework (TDF): the T3 Trial

Target behaviour

Target clinical behaviour (includes timepoint if not immediate)

Location: emergency department

Who performs the behaviour

Triage

All patients presenting to ED with signs and symptoms of suspected acute stroke should be triaged as Australian Triage Scale Category 1 or 2 (seen within 10 min)

ED nurse

Thrombolysis

All patients to be assessed for rt-PA eligibility in ED

All eligible patients to receive rt-PA in ED

ED nurse, ED doctor, Stroke doctor, Stroke nurse

ED doctor, Stroke doctor, Stroke nurse

Temperature management

All patients to have their temperature taken on admission to ED and then at least 4 hourly whilst they remain in ED

Temperature 37.5 °C or greater to be treated with paracetamol (acetaminophen) in ED

ED nurse

ED nurse

Blood glucose management

Venous BGL sample taken to laboratory on admission to ED

Finger prick BGL recorded on admission to ED and finger prick BGL monitored every 6 h (or greater if elevated)

Insulin administered to all patients with BGL > 10 mMol/L within 1 h in ED or stroke unit

ED nurse, ED doctor

ED nurse, Stroke nurse

ED nurse, Stroke nurse, Endocrinologist

Swallow management

Patients to remain NBM until a swallow screen by non-Speech pathologist or swallow assessment by Speech pathologist performed in ED

All patients who fail the swallow screen to remain NBM and have a swallowing assessment by a Speech pathologist whilst in ED

ED nurse, Stroke nurse, ED doctor, Speech pathologist

Speech pathologist

Transfer

All patients with stroke to be discharged from ED within 4 h

All patients with stroke to be admitted to the hospital’s stroke unit

ED nurse, ED doctor, Stroke nurse, Bed manager

ED nurse, Stroke nurse, Bed manager

  1. BGL blood glucose level, ED emergency department, NBM Nil by mouth, rt-PA recombinant tissue plasminogen activator